Q4 sales performance exceeded guidance, driven by better-than-expected sales in Medical Products, Kidney Care, Pharmaceuticals. Baxter reported improved profitability in fourth quarter. Brand New ...

Baxter trades at low valuations with 8x forward cash earnings, debt reduction, cost controls, margin expansion, and $50 2027 ...

Baxter International gets its buy rating from December reaffirmed, agreeing with today's bullish consensus from SA analysts and Wall Street. Positive drivers of the bull call include recent Q4 ...

Baxter International Inc. (NYSE:BAX) Q2 2025 Earnings Call Transcript July 31, 2025 Baxter International Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.6.

As Baxter International Inc (NYSE:BAX) prepares to release its second-quarter 2023 financial results on July 27, Stifel analyst writes it is an opportune time for investors to consider owning BAX ...